Topics

Dutch Antibodies for Autoimmune Diseases Boosted by €15M Series A

11:05 EDT 4 Jul 2019 | Labiotech.eu

The Dutch biotech Citryll has raised €15M to develop antibodies that could fight autoimmune and inflammatory diseases more effectively than current treatments by inhibiting the innate immune system. The Series A funds will be used to launch the clinical development of Citryll’s lead antibody, which is designed to treat the autoimmune condition lupus. The money […]

The post Dutch Antibodies for Autoimmune Diseases Boosted by €15M Series A appeared first on Labiotech.eu.

Original Article: Dutch Antibodies for Autoimmune Diseases Boosted by €15M Series A

NEXT ARTICLE

More From BioPortfolio on "Dutch Antibodies for Autoimmune Diseases Boosted by €15M Series A"

Quick Search

Relevant Topics

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...

Antibodies
An antibody is a protein produced by the body's immune system when it detects harmful substances, called antigens. Examples of antigens include microorganisms (such as bacteria, fungi, parasites, and viruses) and chemicals. Antibodies may be produc...

Autoimmune Disorders
Autoimmune disorders are conditions that occurs when the immune system mistakenly attacks and destroys healthy body tissue. There are more than 80 different types of autoimmune disorders. Normally the immune system's white blood cells help protect ...